Cargando…
Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma
BACKGROUND: Hepatoblastoma (HB) is the most common primary, malignant pediatric liver tumor in children. The treatment results for affected children have markedly improved in recent decades. However, the prognosis for high-risk patients who have extrahepatic extensions, invasion of the large hepatic...
Autores principales: | Zhang, Shu-Cheng, Wang, Wei-Lin, Cai, Wei-Song, Jiang, Kai-Lei, Yuan, Zheng-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488522/ https://www.ncbi.nlm.nih.gov/pubmed/23009685 http://dx.doi.org/10.1186/1471-2407-12-427 |
Ejemplares similares
-
Measles Edmonston Vaccine Strain Derivatives have Potent Oncolytic Activity against Osteosarcoma
por: Musibay, Evidio Domingo, et al.
Publicado: (2014) -
Phase I Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express the Sodium Iodide Symporter in Patients with Recurrent or Refractory Multiple Myeloma
por: Dispenzieri, Angela, et al.
Publicado: (2017) -
Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020) -
Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021) -
Determination Factors Associated with Immune Responses Towards First Dose Edmonston-Zagreb (EZ) Measles Vaccine in Indonesian Infants
por: Teni Nurlatifah, HR, et al.
Publicado: (2021)